Core Laboratories, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
45.00
45.00
40.00
29.00
36.00
-91.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-5.00
7.00
-28.00
-25.00
-24.00
5.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
37.00
56.00
24.00
24.00
36.00
56.00
Cash Flow from Investing Activities
-2.00
-6.00
-6.00
-3.00
-10.00
7.00
Cash Flow from Financing Activities
-31.00
-45.00
-18.00
-23.00
-22.00
-61.00
Net Cash Inflow / Outflow
3.00
4.00
0.00
-2.00
3.00
2.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Core Laboratories, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
45.8960000005019
-429.637
474.00
110.68%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-5.56600000006086
36.821
-41.00
-115.12%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
37.1760000004065
-169.397
206.00
121.95%
Cash Flow from Investing Activities
-2.2310000000244
-4852.904
4,850.00
99.95%
Cash Flow from Financing Activities
-31.2550000003418
5336.627
-5,367.00
-100.59%
Net Cash Inflow / Outflow
3.69000000004035
314.326
-311.00
-98.83%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is -34.07% vs 127.47% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
37.18
56.39
-34.07%






